Market Cap (In INR)
21.73 Billion
Revenue (In INR)
6.3 Billion
Net Income (In INR)
581.87 Million
Avg. Volume
6592.00
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 406.1-1197.0
- PE
- -
- EPS
- -
- Beta Value
- 0.367
- ISIN
- INE0H5O01029
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ms. Komal Gupta
- Employee Count
- -
- Website
- https://windlas.com
- Ipo Date
- 2021-08-16
- Details
- Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO services, including product discovery, product development, licensing, and commercial manufacturing of generic products. It manufactures nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprises fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, and chewable or dispersible. The company was incorporated in 2001 and is based in Gurugram, India.
More Stocks
-
IOLCP
-
0A7O
-
AMC
-
VBAM
-
ISUZYIsuzu Motors Limited
ISUZY
-
VARROCVarroc Engineering Limited
VARROC
-
MISHKAMishka Exim Limited
MISHKA
-
KDH